Cost-effectiveness analysis and return on investment of SunSmart Western Australia to prevent skin cancer
Authors:
Open Access
- 1 August 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Health Promotion International
- Vol. 39 (4)
Abstract
Each year, malignant melanoma accounts for 57 000 deaths globally. If current rates continue, there will be an estimated 510 000 new cases annually and 96 000 deaths by 2040. Melanoma and keratinocyte cancers (KCs) incur a large societal burden. Using a mathematical population model, we performed an economic evaluation of the SunSmart program in the state of Western Australia (WA), a primary prevention program to reduce the incidence of skin cancer, versus no program. A societal perspective was taken combining costs to the health system, patients and lost productivity. The model combined data from pragmatic trial evidence of sun protection, epidemiological studies and national cost reports. The main outcomes modelled were societal and government costs, skin cancer counts, melanoma deaths, life years and quality-adjusted life years. Over the next 20 years, the model predicted that implementing the WA SunSmart program would prevent 13 728 KCs, 636 melanomas and 46 melanoma deaths per 100 000 population. Furthermore, 251 life years would be saved, 358 quality-adjusted life years gained and AU$2.95 million in cost savings to society per 100 000 population would be achieved. Key drivers of the model were the rate reduction of benign lesions from sunscreen use, the costs of purchasing sunscreen and the effectiveness of reducing KCs in sunscreen users. The likelihood of WA SunSmart being cost-effective was 90.1%. For the WA Government, the estimated return on investment was $8.70 gained for every $1 invested. Primary prevention of skin cancer is a cost-effective strategy for preventing skin cancers.Keywords
Funding Information
- Cancer Council Western Australia
- Western Australian Health Promotion Foundation
- Western Australian Department of Health
This publication has 43 references indexed in Scilit:
- Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in AustraliaGenetics in Medicine, 2023
- Health utilities and health‐related quality of life of patients with keratinocyte skin cancersJEADV Clinical Practice, 2023
- Increased melanoma recurrence in patients with multiple primary invasive melanomasJournal of the American Academy of Dermatology, 2022
- To ban or not to ban tanning bed use for minors: A cost‐effectiveness analysis from multiple US perspectives for invasive melanomaCancer, 2021
- Consequences of banning commercial solaria in 2016 in AustraliaHealth Policy, 2020
- Benefit–Cost Analysis of the Danish Sun Safety Campaign 2007–2015: Cost Savings from Sunburn and Sunbed Use Reduction and Derived Skin Cancer Reductions 2007–2040 in the Danish PopulationPharmacoEconomics - Open, 2019
- The potential impact of reducing indoor tanning on melanoma prevention and treatment costs in the United States: An economic analysisJournal of the American Academy of Dermatology, 2017
- Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness AnalysesJAMA, 2016
- Clinical Skin Examination Outcomes After a Video-Based Behavioral InterventionJAMA Dermatology, 2014
- A Randomized Controlled Trial to Assess Sunscreen Application and Beta Carotene Supplementation in the Prevention of Solar KeratosesArchives of Dermatology, 2003